Agenda
17/01/2018 - 14:00 - Sala Xipre, 173.06

Antitumor effects of novel targeted therapies (TAK-228 and TAK-117) with high selectivity against PI3K/AKT/mTOR pathway in bladder cancer. Defining molecular markers


Scientific sessions

Anna Hernández

Grup de Recerca en Teràpia Molecular del Càncer, IMIM